Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C transmission and prevention news

Show

From To
Vaccination could have important role in control of UK HCV epidemic among people who inject drugs

A vaccine, even with low efficacy, could lead to meaningful reductions in the incidence and prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID),

Published
30 June 2016
By
Michael Carter
Many US communities vulnerable to HIV outbreak due to unsafe injecting of prescription opioids

Research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes has identified the jurisdictions in the United States especially vulnerable to the rapid spread

Published
21 June 2016
By
Michael Carter
Could hepatitis C treatments help prevent virus transmission?

In a study looking specifically at HCV infection rates in HIV-positive gay men, the researchers found the proportion of HIV positive gay men with HCV increased slightly from 2004 to 2011, and that current treatment rates were unlikely to reduce HCV transmission over time.

Published
19 May 2016
From
Eurekalert Inf Dis
Outside the biomedical box of hepatitis C research

Interview with Magdalena Harris, Lecturer at the London School of Hygiene and Tropical Medicine, on how she came to work with viral hepatitis, how the field has been changing, and what new research is called for.

Published
17 May 2016
From
BioMed Central blogs
WHO issues new hepatitis C guidelines, EASL guidelines update forthcoming in September

In April, coinciding with the 2016 International Liver Congress in Barcelona, the World Health Organization (WHO) released an update to its Guidelines for the screening, care and treatment

Published
12 May 2016
By
Liz Highleyman
Hepatitis C kills more people than any other infectious disease in US, CDC says

The number of deaths due to hepatitis C is at an all-time high in the US and exceeds those attributable to 60 other infectious diseases including

Published
06 May 2016
By
Liz Highleyman
The Drugs Consensus Is Not Pretty - It's Been Ripped Apart at the Seams

The UNGASS was certainly not a success for the defenders of the status quo. The consensus on punitive prohibition has been well and truly ripped apart at the seams. This UNGASS demonstrates the impact civil society pressure can achieve. The drug policy reform movement will continue to grow into a formidable global social movement towards 2019. The collective demand for change will grow ever louder leading to sustainable and seismic break-throughs at national, regional and ultimately UN levels.

Published
04 May 2016
From
International Drug Policy Consortium
AIDS expert to head $5-million research efforts on hepatitis C

Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and men who have sex with men. It will concentrate on people who have already taken medication that clears them of the hepatitis C virus, but who could be reinfected if they have blood-to-blood contact with another person. They will be encouraged to prevent that by using condoms, not sharing needles and taking part in support programs through Vancouver Coastal Health, one of the five organizations involved in the program.

Published
22 April 2016
From
Vancouver Sun
High incidence of HCV reinfection among HIV-positive MSM in Western Europe

There is a very high incidence of hepatitis C virus (HCV) reinfection among HIV-positive men who have sex with men (MSM) in western Europe, according to research

Published
19 April 2016
By
Michael Carter
Hepatitis C: Let’s not forget ‘prevention as prevention’

Interview with Eberhard Schatz, one of the two coordinators of Correlation, the European social inclusion and health network.

Published
14 April 2016
From
BioMed Central blogs
← First12345...24Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close